Zosano Pharma Corporation (ZSAN)

4.07 +0.09 (+2.261%)

IEX Real-Time Price

September 25, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 3.98

Price Open 3.97

Volume: 73,924

Avg Volume: 104,730

Market Cap: 48.73M

P/E Ratio -0.32

52 Wk Range 3.6101-25.8



ZSAN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-08-31
10.48M
1.64M
11.14
15.66%

2018-08-15
10.48M
1.73M
5.32
16.52%

2018-07-31
10.48M
1.7M
4.64
16.26%

2018-07-13
10.48M
1.58M
5.31
15.10%




ZSAN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-09
Q2 2018
AMC
0.00 (0)
-0.75
0.00

2018-05-15
Q1 2018
AMC
0.00 (0)
-0.75
0.00

2018-05-08
Q1 2018
N/A
-5.40 (1)
-0.75
0.00

2018-03-12
Q4 2017
N/A
-4.80 (1)
-0.75
0.00

News

Zosano Pharma Corporation (ZSAN) CEO John Walker on Q2 2018 Results - Earnings Call Transcript (2018-08-09 21:53 SeekingAlpha)

Zosano Pharma Corporation (ZSAN) Q2 2018 Earnings Conference Call August 09, 2018 4:30 PM ET Executives Carol Lizak - Senior Director and Corporate Controller John Walker - Chief Executive Officer Donald Kellerman - Vice President of Clinical Development & Medical Affairs P…

 


Statistics

Shares Outstanding: 11.97M

Top 15 Institution Percent: 29.00

Price To Sales: N/A

Price To Book: 1.34

Revenue: N/A

Gross Profit: N/A

Cash: 19.85M

Debt: 8.18M

Return On Assets: -80.35

Return On Equity: -110.72

Profit Margin: N/A

Price History

Beta: 1.94

50-day Moving Avg: 4.15

200-day Moving Avg: 6.56

YTD Change: -62.45

5-day Change: 1.27

1-month Change: -1.49

3-month Change: -0.50

6-month Change: -72.65

1-year Change: -76.30

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Zosano Pharma Corporation

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.zosanopharma.com

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications.